Skip to main content

Table 2 Comorbidities

From: Comorbidities and COVID-19 status influence the survival rate of geriatric patients in intensive care units: a prospective cohort study from the Indonesian Society of Anaesthesiology and Intensive Therapy

Comorbidities

Survivors n = 317 (56.4%)

Non-Survivors n = 245 (43.6%)

Total (n = 563)

p-value (OR; CI 95%)

Hypertension

112 (53.6%)

97 (46.4%)

209 (21.1%)

0.002* (1.65; 1.19-2.30)

Diabetes

83 (51.9%)

77 (48.1%)

160 (16.2%)

0.002* (1.73; 1.21-2.47)

Moderate-to-severe renal disease

43 (41%)

62 (59%)

105 (10.6%)

< 0.005* (2.77; 1.81-4.23)

Congestive heart failure

48 (52.7%)

43 (47.3%)

91 (9.2%)

0.046* (1.56; 1.0-2.43)

Cerebrovascular disease

44 (48.9%)

46 (51.1%)

90 (9.1%)

0.005* (1.86; 1.19-2.91)

Tumour (benign or malignant)

56 (62.9%)

33 (37.1%)

89 (9.0%)

0.885

Prior myocardial infarction

41 (70.7%)

17 (29.3%)

58 (5.9%)

0.166

Peripheral vascular disease

24 (57.1%)

18 (42.9%)

42 (4.2%)

0.484

Chronic pulmonary disease

12 (42.9%)

16 (57.1%)

28 (2.8%)

0.031* (2.27; 1.05-4.87)

Diabetes with chronic complications

6 (23.1%)

20 (76.9%)

26 (2.6)

< 0.005* (5.83; 2.31-14.73)

Moderate or severe liver disease

10 (43.5%)

13 (56.5%)

23 (2.3%)

0.06

Mild liver disease

11 (53.4%)

10 (47.6%)

21 (2.1%)

0.345

Dementia

5 (38.5%)

8 (61.5%)

13 (1.3%)

0.075

Non-CVD neurologic disease

7 (53.8%)

6 (46.2%)

13 (1.3%)

0.529

Metastatic solid tumor

6 (50%)

6 (50%)

12 (1.2%)

0.378

Peptic ulcer disease

3 (50%)

3 (50%)

6 (0.6%)

0.535

Rheumatologic disease

0

2 (100%)

2 (0.2%)

0.069

Leukemia

0

1 (100%)

1 (0.1%)

0.199

Lymphoma

0

0

0 (0.0%)

n/a

Acquired immunodeficiency syndrome (AIDS)

0

0

0 (0.0%)

n/a

  1. *Chi-square test